The U.S. Senate reached a bipartisan deal on Monday to provide $10 billion in additional COVID-19 funding that will be used to purchase therapeutics and vaccines and also prop up the country’s testing capacity in the event of another surge in cases.

                By                    Vance Cariaga                

See: How Rich Is Former President Donald Trump? Find: How Much Is President Joe Biden Worth?

The money essentially repurposes unspent COVID funds, Reuters reported. And although it was applauded by lawmakers across the political aisle — including Senate Majority Leader Chuck Schumer (D-N.Y.) and Sen. Mitt Romney (R-Utah) — the dollar value is less than half of the $22.5 billion the Biden administration had sought.

Schumer also expressed disappointment that the bill does not include $5 billion in global health funding to spread vaccines around the world.

More From Your Money: Choose a high-interest saving, checking, CD, or investing account from our list of top banks to start saving today.

The proposed bill earmarks at least $5 billion to buy and develop COVID-19 treatments such as antiviral pills, CNBC reported. Another $750 million will go toward developing vaccines that target specific variants and expanding vaccine production capacity in the U.S. if needed.

The bill must now get House approval before it can be signed into law by President Joe Biden.

“We urge Congress to move promptly on this $10 billion package because it can begin to fund the most immediate needs, as we currently run the risk of not having some critical tools like treatments and tests starting in May and June,” White House press secretary Jen Psaki said in a statement.

She also said the White House will work with Congress to pass more aid, but that might be a tough sell. As Reuters noted, Senate Republicans demanded that any new requests for COVID funding be paid for by recycling existing money from prior COVID relief funds. Biden might have a hard time convincing them to approve new pandemic funding.

House Democrats in March sought to approve $15 billion in COVID funding, but Republicans insisted on repurposing funds that were already appropriated for state and local governments to cover any new spending. The bill moved to the Senate after the House failed to reach a bipartisan agreement.

Child Tax Credit Revival: Romney Fighting for Major Revisions and Bipartisan Support Find: COVID-19 Testing & Treatment Will No Longer Be Free As Uninsured Program Runs Out of Money

Under terms of the Senate bill, about $2.3 billion was cut from a COVID program to boost aviation manufacturing and repair businesses. It also eliminates nearly $2 billion in grant funding for shuttered venues such as live performance venues, museums and movie theaters.

  • Dollar Tree: 5 High-Quality Items To Buy NowDo You Have a Tax Question? Ask a Tax ProThe 10 Best Cash Back Credit Cards for 20236 Reasons Why You Shouldn’t Procrastinate on Your Taxes